跳至主要内容
临床试验/ACTRN12622001495718
ACTRN12622001495718尚未招募未知

Prevention and treatment of chemotherapy induced nausea and vomiting using music therapy interventions for people undergoing medium or high risk emetogenic chemotherapy

Flinders Foundation0 个研究点目标入组 24 人开始时间: 2022年11月29日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Participants who are planned to undergo systemic therapy for their cancer with regimen that are medium emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy.
  • 2.Capable of giving signed informed consent.
  • 3.Able to understand English.

排除标准

  • 1.Previously have had chemotherapy
  • 2.Planned for or prior cranial radiotherapy
  • 3.Established cognitive impairment
  • 4.Significant baseline nausea and vomiting from cancer or other diseases such as bowel or gastric outlet obstruction
  • 5.Pregnant at study entry
  • 6.Known significant hearing impairment not corrected by hearing aids

研究者

相似试验